These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6788915)

  • 1. Dental pain and adaptive strain; a place for fatty acid cyclo-oxygenase inhibition.
    Schwartz HS
    J Oral Med; 1981; 36(2):31-4. PubMed ID: 6788915
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model.
    Ehrich EW; Dallob A; De Lepeleire I; Van Hecken A; Riendeau D; Yuan W; Porras A; Wittreich J; Seibold JR; De Schepper P; Mehlisch DR; Gertz BJ
    Clin Pharmacol Ther; 1999 Mar; 65(3):336-47. PubMed ID: 10096266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral analgesics for acute dental pain.
    Weinberg MA; Fine JB
    Dent Today; 2002 Jul; 21(7):92-7. PubMed ID: 12242841
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in the sensitivity of behavioural measures of pain to the selectivity of cyclo-oxygenase inhibitors.
    Huntjens DR; Spalding DJ; Danhof M; Della Pasqua OE
    Eur J Pain; 2009 May; 13(5):448-57. PubMed ID: 18774319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclo-oxygenase 2 inhibitors: an important new drug classification.
    Kessenich CR
    Pain Manag Nurs; 2001 Mar; 2(1):13-8. PubMed ID: 11705156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous opioids mediate the hypoalgesia induced by selective inhibitors of cyclo-oxygenase 2 in rat paws treated with carrageenan.
    França DS; Ferreira-Alves DL; Duarte ID; Ribeiro MC; Rezende RM; Bakhle YS; Francischi JN
    Neuropharmacology; 2006 Jul; 51(1):37-43. PubMed ID: 16620880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 inhibition and the control of pain.
    Kiefer W; Dannhardt G
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1348-58. PubMed ID: 12498012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cyclo-oxygenase 2 inhibitors and cancer].
    André T; Soria JC
    Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
    [No Abstract]   [Full Text] [Related]  

  • 9. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
    Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acemetacin and indomethacin: differential inhibition of constitutive and inducible cyclo-oxygenases in human gastric mucosa and leucocytes.
    Tavares IA; Bennett A
    Int J Tissue React; 1993; 15(2):49-53. PubMed ID: 8144313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of opioid inhibition of GABAergic synaptic transmission by cyclo-oxygenase inhibitors in rat periaqueductal grey neurones.
    Vaughan CW
    Br J Pharmacol; 1998 Apr; 123(8):1479-81. PubMed ID: 9605550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of indomethacin on the metabolism and cytokine secretion of human aneurysmal aorta.
    Franklin IJ; Walton LJ; Greenhalgh RM; Powell JT
    Eur J Vasc Endovasc Surg; 1999 Jul; 18(1):35-42. PubMed ID: 10388637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coxibs: highly selective cyclooxygenase-2 inhibitors. Part I. Clinical efficacy].
    Burdan F; Korobowicz A
    Pol Merkur Lekarski; 2003 Apr; 14(82):348-51. PubMed ID: 12868200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide.
    Rainsford KD
    Inflammopharmacology; 2006 Aug; 14(3-4):120-37. PubMed ID: 16983492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
    Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man.
    Bachi A; Brambilla R; Fanelli R; Bianchi R; Zuccato E; Chiabrando C
    Br J Pharmacol; 1997 Aug; 121(8):1770-4. PubMed ID: 9283716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S; Santucci L; Distrutti E
    Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunction of the cyclo-oxygenase pathway in the foetoplacental circulation in Type 1 diabetes mellitus.
    Bisseling TM; Wouterse AC; Steegers EA; Elving L; Russel FG; Smits P
    Diabet Med; 2005 Apr; 22(4):503-6. PubMed ID: 15787680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the ductus arteriosus from foetal lamb: differential development and change by oxygen and endotoxin.
    Coceani F; Ackerley C; Seidlitz E; Kelsey L
    Br J Pharmacol; 2001 Jan; 132(1):241-51. PubMed ID: 11156583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.